Page last updated: 2024-08-21

fluorobenzenes and Parathyroid Neoplasms

fluorobenzenes has been researched along with Parathyroid Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asan, E; Bodur, E; Canpinar, H; Gulcelik, NE; Kaymaz, FF; Sarisozen, C; Usman, A; Vural, I; Zeybek, ND	1

Other Studies

1 other study(ies) available for fluorobenzenes and Parathyroid Neoplasms

Article	Year
Rosuvastatin induces apoptosis in cultured human papillary thyroid cancer cells. The Journal of endocrinology, 2011, Volume: 210, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Autophagy; Carcinoma, Papillary; Caspase 3; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Fluorobenzenes; G1 Phase; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Situ Nick-End Labeling; Ki-67 Antigen; Microscopy, Electron, Transmission; Osmolar Concentration; Parathyroid Neoplasms; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Time Factors; Vacuoles	2011

Article

Year

Rosuvastatin induces apoptosis in cultured human papillary thyroid cancer cells.

The Journal of endocrinology, 2011, Volume: 210, Issue:1

Topics: Antineoplastic Agents; Apoptosis; Autophagy; Carcinoma, Papillary; Caspase 3; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Fluorobenzenes; G1 Phase; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Situ Nick-End Labeling; Ki-67 Antigen; Microscopy, Electron, Transmission; Osmolar Concentration; Parathyroid Neoplasms; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Time Factors; Vacuoles

2011